Similarly, Bifidobacterium has been used as an adjuvant in hepatocellular carcinoma to inhibit tumor growth, increase IFN-γ secretion, and downregulate the JAK/STAT3 pathway [119]. This evidence concerns the gene STAT3 and neoplasm.